Free Access
Med Sci (Paris)
Volume 23, Number 4, Avril 2007
Page(s) 371 - 378
Section M/S revues
Published online 15 April 2007
  1. Mestecky J, Lamm ME, Strober W, et al. Mucosal immunology, 3rd ed. San Diego: Academic Press, 2005 : 1868 p. [Google Scholar]
  2. Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 2003; 3 : 331–41. [Google Scholar]
  3. Kelsall BL, Leon F. Involvement of intestinal dendritic cells in oral tolerance, immunity to pathogens, and inflammatory bowel disease. Immunology 2005; 6 : 132–48. [Google Scholar]
  4. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001; 2 : 725–31. [Google Scholar]
  5. Salmi M, Jalkanen S. Lymphocyte homing to the gut: attraction, adhesion and commitment. Immunol Rev 2001; 206 : 100–13. [Google Scholar]
  6. Stagg AJ, Kamm MA, Knight SC. Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin. Eur J Immunol 2002; 32 : 1445–54. [Google Scholar]
  7. Mora JR, Bono MR, Manjunath N, et al. Selective imprinting of gut-homing T cells by Peyer’s patch dendritic cells. Nature 2003; 424 : 88–93. [Google Scholar]
  8. Iwata M, Hirakiyama A, Eshima Y, et al. Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004; 21 : 527–38. [Google Scholar]
  9. Johansson-Lindbom B, Svensson M, Pabst O, et al. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J Exp Med 2005; 202 : 1063–73. [Google Scholar]
  10. Annacker O, Coombes JL, Malmstrom V, et al. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J Exp Med 2005; 202 : 1051–61. [Google Scholar]
  11. Lazarus NH, Kunkel EJ, Johnston B, et al. A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts. J Immunol 2003; 170 : 3799–805. [Google Scholar]
  12. Abonia JP, Hallgren J, Jones T, et al. Alpha-4 integrins and VCAM-1, but not MAdCAM-1, are essential for recruitment of mast cell progenitors to the inflamed lung. Blood 2006; 108 : 1588–94. [Google Scholar]
  13. Quiding M, Nordstrom I, Kilander A, et al. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses, gamma-interferon production, and evokes local immunological memory. J Clin Invest 1991; 88 : 143–8. [Google Scholar]
  14. Kozlowski PA, Cu-Uvin S, Neutra MR, Flanigan TP. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun 1997; 65 : 1387–94. [Google Scholar]
  15. Johansson EL, Wassén L, Holmgren J, et al. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans. Infect Immun 2001; 69 : 7481–6. [Google Scholar]
  16. Hornquist CE, Ekman L, Grdic KD, et al. Paradoxical IgA immunity in CD4-deficient mice. Lack of cholera toxin-specific protective immunity despite normal gut mucosal IgA differentiation. J Immunol 1995; 155 : 2877–87. [Google Scholar]
  17. Goodrich ME, McGee DW. Regulation of mucosal B cell immunoglobulin secretion by intestinal epithelial cell-derived cytokines. Cytokine 1998; 10 : 948–55. [Google Scholar]
  18. Kunisawa J, Kiyono H. A marvel of mucosal T cells and secretory antibodies for the creation of first lines of defense, Cell Mol Life Sci 2005; 62 : 1308–21. [Google Scholar]
  19. Franco MA, Greenberg HB. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol 1995; 69 : 7800–6. [Google Scholar]
  20. Klavinskis LS, Bergmeier LA, Gao L, et al. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes. J Immunol 1996; 157 : 2521–7. [Google Scholar]
  21. Luci C, Hervouet C, Rousseau D, et al. Dendritic cell-mediated induction of cytotoxic responses following intravaginal immunization with the non-toxic B subunit of cholera toxin. J Immunol 2006; 176 : 2749–57. [Google Scholar]
  22. Simmons CP, Hussell T, Sparer T, et al. Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses. J Immunol 2001; 166 : 1106–13. [Google Scholar]
  23. Ermak TH, Giannasca PJ, Nichols R, et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 1998; 188 : 2277–88. [Google Scholar]
  24. Wu HY, Weiner HL. Oral tolerance. Immunol Res 2003; 28 : 265–84. [Google Scholar]
  25. Stassen M, Fondel S, Bopp T, et al. Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur J Immunol 2004; 34 : 1303–11. [Google Scholar]
  26. Hanninen A, Harrison LC. Gamma delta T cells as mediators of mucosal tolerance: the autoimmune diabetes model. Immunol Rev 2000; 173 : 109–19. [Google Scholar]
  27. Crispe IN Hepatic T cells and liver tolerance. Nat Rev Immunol 2003; 3 : 51–62. [Google Scholar]
  28. Smith PD, Ochsenbauer-Jambor C, Smythies LE. Intestinal macrophages: unique effector cells of the innate immune system. Immunol Rev 2005; 206 : 149–59. [Google Scholar]
  29. Smythies LE, Sellers M, Clements RH, et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 2005; 115 : 66–75. [Google Scholar]
  30. Anjuere F, Luci C, Lebens M, et al. In vivo adjuvant-induced mobilization and maturation of gut dendritic cells after oral administration of cholera toxin. J Immunol 2004; 173 : 5103–11. [Google Scholar]
  31. Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005; 11 : S45–53. [Google Scholar]
  32. Holmgen J, Adamsson J, Anjuere F, et al. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunol Lett 2005; 9 : 181–8. [Google Scholar]
  33. Chaillous L, Lefevre H, Thivolet C, et al. Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Lancet 2000; 12 : 545–9. [Google Scholar]
  34. Wiendl H, Hohlfeld R. Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials. BioDrugs 2002; 16 : 183–200. [Google Scholar]
  35. Stanford M, Whittall T, Bergmeier LA, et al. Oral tolerization with peptide 336–351 linked to cholera toxin B subunit preventing relapses of uveitis in Behcet’s disease. Clin Exp Immunol 2004; 137 : 201–8. [Google Scholar]
  36. Tacket CO, Sztein MB, Losonsky GA, et al. Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin Immunol 2003; 108 : 241–7. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.